878120P

C18 Lyso PAF

Avanti Research^™ - A Croda Brand 878120P, powder

• 别名: 1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphocholine
• 经验公式（希尔记法）: C₂₆H₅₆NO₆P
• CAS号: 74430-89-0
• 分子量: 509.70
• MDL號碼: MFCD00065889
• 分類程式碼代碼: 12352211
• NACRES: NA.25

属性

• 形狀: powder
• 包裝: pkg of 1 × 5 mg (878120P-5mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 878120P
• 脂質類型: bioactive lipids; phosphoglycerides
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COCCCCCCCCCCCCCCCCCC
• InChI: 1S/C26H56NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22-31-24-26(28)25-33-34(29,30)32-23-21-27(2,3)4/h26,28H,5-25H2,1-4H3/t26-/m1/s1
• InChI 密鑰: XKBJVQHMEXMFDZ-AREMUKBSSA-N

说明

一般說明

C18-lysoPAF, also known as 1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphocholine, is a synthetic lyso-platelet activating factor (PAF). It is a precursor and metabolite of 1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine (C18:0 PAF). Lyso-platelet activating factor (PAF) is synthesized from PAF acetylhydrolases by the degradation of PAF. Additionally, it is also synthesized in the remodeling pathway from 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine (1-alkyl-phosphatidylcholine) by the enzyme phospholipase.

應用

C18-lysoPAF (1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphocholine) has been used to study its effect on human eosinophil degranulation.

包裝

5 mL Amber Glass Screw Cap Vial (878120P-5mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全信息

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable